Dexcom Inc (NASDAQ:DXCM)

80.50
Delayed Data
As of 4:01pm ET
 -1.60 / -1.95%
Today’s Change
66.89
Today|||52-Week Range
164.86
-40.03%
Year-to-Date
3 Reasons to Hold DexCom (DXCM) Stock in Your Portfolio
11:25am / Zacks.com - Paid Partner Content
Nasdaq Bear Market: 3 of the Best Growth Stocks to Buy Today
Sep 22 / MotleyFool.com - Paid Partner Content
Better Growth Stock: Intuitive Surgical vs. DexCom
Sep 28 / MotleyFool.com - Paid Partner Content
3 Highly Profitable Stocks That Are Super Cheap Right Now
Sep 21 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close82.10
Today’s open82.59
Day’s range80.44 - 83.98
Volume66,265
Average volume (3 months)3,094,261
Market cap$31.7B
Data as of 4:01pm ET, 09/30/2022

Growth & Valuation

Earnings growth (last year)-69.41%
Earnings growth (this year)+19.81%
Earnings growth (next 5 years)+38.45%
Revenue growth (last year)+27.08%
P/E ratio192.8
Price/Sales21.95
Price/Book13.90

Competitors

 Today’s
change
Today’s
% change
BAXBaxter International...-1.39-2.51%
ZBHZimmer Biomet Holdin...-2.30-2.15%
WSTWest Pharmaceutical ...-5.02-2.00%
PODDInsulet Corp-1.90-0.82%
Data as of 4:02pm ET, 09/30/2022

Financials

Next reporting dateOctober 28, 2022
EPS forecast (this quarter)$0.24
Annual revenue (last year)$2.4B
Annual profit (last year)$154.7M
Net profit margin6.32%

Profile

Sector
Health Technology
Industry
Medical Specialties
No executives to display
Corporate headquarters
San Diego, California

Forecasts